China Shineway Pharmaceutical

China Shineway Pharmaceutical's reported carbon emissions

In 2021, China Shineway Pharmaceutical reported total carbon emissions of approximately 117,794,000 kg CO2e, which includes Scope 1 emissions of about 76,087,000 kg CO2e, Scope 2 emissions of approximately 16,885,000 kg CO2e, and Scope 3 emissions of about 24,822,000 kg CO2e. This data is cascaded from its parent company, China Shineway Pharmaceutical Group Limited. As of 2024, there is no updated emissions data available, and the company has not disclosed any specific reduction targets or climate commitments. The absence of disclosed data for subsequent years indicates a potential gap in their climate reporting. China Shineway Pharmaceutical's emissions intensity metrics, such as GHG intensity per employee, suggest a focus on understanding their carbon footprint relative to operational metrics. However, without formal reduction initiatives or targets, the company's climate strategy remains unclear. Overall, while the company has reported emissions data, its commitment to reducing carbon emissions and addressing climate change appears limited at this time.